Outcome of Analyst/Investors meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals' management held a group conference call with analysts and investors on December 16, 2025, from 11:30 AM to 12:40 PM IST. The event was themed 'Beyond the Numbers - Value Discovery Summit-2025'. The interaction followed a Q&A format, with no formal presentation made by the company. The company explicitly stated that no Unpublished Price Sensitive Information (UPSI) was shared during the meeting. The intimation was filed under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, signed by Managing Director Fredun Medhora.
This is a routine compliance filing with no new financial details, guidance, or material disclosures. Shareholders should not expect any immediate impact on stock price or fundamentals, as the company itself confirms no sensitive information was shared.